| Meetings | ||
|---|---|---|
 |
||
|
||
|
||
|
||
|
||
Washington, DC - November 3, 2005 Panelists Christopher J. Conover, Ph.D.
Christopher J. Conover is assistant research professor of public policy studies in the Terry Sanford Institute of Public Policy, senior fellow in the Center for Health Policy at Duke University, and Director of the Health Policy Certificate Program. He received his doctorate in policy analysis from the RAND Graduate School. His research interests are in State health policy, with a focus on issues related to health care for the medically indigent, estimating the magnitude of the social burden of illness, and health regulation. He teaches in the Terry Sanford Institute of Public Policy and the Duke University School of Medicine. Dr. Conover has provided policy advice on access and cost issues to Governors and legislative groups at the Federal and State levels. He has recently testified before Congress on the economic costs of health care regulation, publishing Health Care Regulation: A $169 Billion Hidden Tax. Dr. Conover has served as a consultant to the North Carolina Health Reform Commission, served 4 years as a Governor-appointed member of the North Carolina Council on Health Policy Information, and was a member of the Task Force on Child Health Insurance. He also has developed the Health Policy Cyberexchange (http://www.hpolicy.duke.edu/cyberexchange) and Who's Who in Health Policy (http://www.hpolicy.duke.edu/cyberexchange/whowho.html) in hopes of using the Internet to foster more evidence-based health policy decisions. Ted Frech is Professor of Economics at the University of California, Santa Barbara, an adjunct professor at Sciences Po in Paris and an adjunct scholar at the American Enterprise Institute in Washington, D.C. He has been a visiting professor at Harvard University and at the University of Chicago and an economist in the U.S. Government, in the predecessor of the Department of Health and Human Services. He received his B.S. in industrial engineering from the University of Missouri in 1968 and his Ph.D. in economics from the University of California, Los Angeles in 1974. Prof. Frech has published over 100 articles and books on health care and regulation. His research has included health insurance and managed care, optimal scale of physician practices and hospitals, physician and hospital pricing, competition, monopoly and antitrust policy, ownership, efficiency and wages in nursing homes, the production of health, distance traveled to hospitals, supplemental insurance in Medicare, malpractice reform and private health insurance in Australia. Prof. Frech has consulted on the economics of health care for private and public organizations and has testified in U.S. federal and state courts, state legislatures, state and federal regulatory bodies and in the U.S. Congress.
Dr. Richard Lawlor serves as Director of Outreach and Advisor to the Administrator of the Centers for Medicare & Medicaid Services (CMS). In this capacity, he advises on provider and beneficiary communication strategies, manages outreach and education programs in the CMS Office of External Affairs, and facilitates the agency response or resolution to various policy concerns related to coverage and payment. In performing this role, he coordinates the handling of a broad range of issues across CMS working divisions, while serving as a liaison to the Department of Health and Human Services, other DHHS agencies, and key stakeholder groups. He is responsible for ensuring that the regulatory concerns and perspectives of groups such as physicians, suppliers, and health facilities are appropriately recognized and leveraged in the policy development and implementation processes. He serves on multiple agency working groups supporting the implementation of the Medicare Prescription Drug Benefit and other provisions of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. Dr. Lawlor began his government service as a Health Scientist at the Food and Drug Administration, where he worked in both the Office of the Commissioner and the Office of the Ombudsman. While at the FDA, he helped to establish the Office of Combination Products, and to develop and codify the standard operating procedures and policies for FDA inter-center reviews. His duties also included facilitating agency determinations of the primary mode of action of specific drugs, biologics and medical devices, in order to determine the FDA regulations that sponsor companies would need to follow. The combined experiences at FDA and CMS give him expertise on many subjects within the scope of the regulatory authority at both agencies. Dr. Lawlor also brings a unique perspective to his current role because of his background as a health care provider. He previously ran his own chiropractic and sports medicine practice in Austin, Texas and learned firsthand the issues associated with the physician office setting, ranging from independent practice management to insurance reimbursement and health plan provider network development. During this time, he served in leadership roles at both state and local professional associations, was active in volunteer services and sat on local health boards. After practicing for eight years, Dr. Lawlor sold his practice and returned to graduate school. He earned a Masters in Business Administration while also working at pioneer internet health company drkoop.com.
Mark A. Hall is Professor of Law and Public Health at Wake Forest University School of Law and School of Medicine. He is also an Associate in Management at the Babcock School of Management. Prof. Hall specializes in health care law and public policy, with a focus on economic, regulatory and corporate issues. His present research interests include doctor/patient trust, managed care regulation, health care rationing, genetics, and insurance market reform. He is the author or editor of ten books on health care law and policy, including the 4-volume series Health Care Corporate Law (Aspen), Making Medical Spending Decisions (Oxford University Press), and Health Care Law and Ethics (5th ed., Aspen).
Michael Morrisey is a professor of health economics and health insurance at the University of Alabama at Birmingham, School of Public Health. He is also director of the UAB Lister Hill Center for Health Policy. Dr. Morrisey is the author of four books and over 130 papers on health economics and health policy topics. His research interests include: employer-sponsored health insurance, regulation in health care markets, and issues of hospital economics. He is currently involved in research projects dealing with employee premium contributions for family coverage, the effects of motor vehicle laws affecting the youngest and oldest drivers, and the effects of medical malpractice reform on health insurance premiums. Dr. Morrisey is a member of the editorial boards of Health Affairs, Health Services and Outcomes Research Methodology, and Medical Care Research and Review; he is the former Secretary/Treasurer of the International Health Economics Association; a Fellow of the Employee Benefits Research Institute, and an adjunct scholar at the American Enterprise Institute. He was the first recipient of the John Thompson Young Investigator Award for health services research given by the Association of University Programs in Health Administration. In 2000 Dr. Morrisey was the recipient of the UAB School of Public Health Distinguished Investigator Award and in 2001 received the UAB School of Public Health President’s Award for Teaching. He holds a Ph.D. in economics from the University of Washington (Seattle).
Dan Mulholland holds a BA and MA from Duquesne University, and a JD from the University of Pittsburgh. Mr. Mulholland is a senior partner in Horty, Springer & Mattern. He serves as a faculty member of the Estes Park Institute and as Chair of the Credentialing and Peer Review Practice Group of the American Health Lawyers Association. He was named one of 40 health care attorneys in the country who have made their mark by the National Law Journal. He has spoken and written extensively concerning a wide variety of health law topics and works extensively on hospital corporate and physician contract matters, managed care and integrated delivery system contracts and development, and litigation. He is nationally known for his expertise in strategic counseling to boards regarding mergers, acquisitions, joint ventures and affiliations.
|